10/17/2024
3:54 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 15-12G | |
10/04/2024
3:21 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024
3:24 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024
3:27 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024
3:30 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024
3:33 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024
3:36 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024
3:18 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024
3:16 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form POSASR | |
08/27/2024
9:14 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/15/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC 13D/A | |
Get the Latest News and Ratings for MOR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for MorphoSys and its competitors with MarketBeat's FREE daily newsletter. |
08/13/2024
3:31 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/07/2024
3:51 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
| Form SC 14D9/A | |
08/07/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/05/2024
7:14 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/02/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/01/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/31/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/30/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/29/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/25/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/25/2024
3:05 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 25
Notification of the removal from listing and registration of matured, redeemed or retired securities | |
07/18/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/18/2024
10:25 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/12/2024
3:20 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/11/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/05/2024
5:48 AM | MorphoSys (Subject)
MorphoSys AG (Subject)
| Form SC 14D9 | |
07/05/2024
5:02 AM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T | |
07/02/2024
9:18 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/21/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/21/2024
9:07 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2024
3:41 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2024
3:33 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
| Form SC14D9C | |
06/20/2024
2:38 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-C | |
06/17/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/10/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/10/2024
11:06 AM | GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
MorphoSys (Subject)
MorphoSys AG (Subject)
| Form SC 13G/A | |
06/10/2024
10:01 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/06/2024
3:36 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/05/2024
9:22 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/04/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
This Crypto Is Set to Explode in February (Ad) It's a groundbreaking opportunity that could be poised for extraordinary gains.
The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW |
06/04/2024
9:17 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/31/2024
9:17 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/29/2024
9:17 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2024
9:16 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/24/2024
9:13 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2024
1:19 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
| Form SC 14D9/A | |
05/23/2024
9:11 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2024
8:04 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/21/2024
9:07 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/17/2024
9:15 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/16/2024
3:43 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
| Form SC 14D9/A | |
05/16/2024
3:31 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/16/2024
9:11 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/15/2024
9:09 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/14/2024
9:27 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/13/2024
9:19 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/10/2024
9:31 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/08/2024
9:08 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2024
3:45 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/07/2024
9:24 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/06/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/06/2024
9:07 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/03/2024
9:29 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/02/2024
3:31 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/02/2024
9:43 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/30/2024
9:07 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/30/2024
7:57 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024
3:15 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024
9:17 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/26/2024
9:11 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/25/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/25/2024
9:38 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/24/2024
10:03 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/23/2024
9:14 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/22/2024
9:32 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/19/2024
9:17 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/18/2024
3:31 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/18/2024
1:33 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC 13D | |
04/18/2024
9:13 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/17/2024
3:49 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
| Form SC 14D9/A | |
04/17/2024
3:30 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/16/2024
4:07 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/16/2024
9:12 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/15/2024
2:44 PM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/12/2024
9:54 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/11/2024
10:57 AM | MorphoSys (Subject)
MorphoSys AG (Subject)
| Form SC 14D9 | |
04/11/2024
5:01 AM | MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T | |
04/09/2024
9:07 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024
9:19 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2024
9:15 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
NVDA Crash Update (Ad) An overseas AI rival sent shockwaves through the U.S. tech market last week...
Leaving millions of investors worrying – Is this the end of the great AI bull run? We've outlined the exact steps to take in a free interview. |
04/02/2024
9:08 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/27/2024
12:16 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/26/2024
10:15 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/25/2024
10:37 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/22/2024
10:17 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/22/2024
5:47 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/21/2024
10:27 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024
3:12 PM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024
10:13 AM | MorphoSys (Filer)
MorphoSys AG (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
